WO2004066939A3 - Controlled-release drug delivery system - Google Patents

Controlled-release drug delivery system Download PDF

Info

Publication number
WO2004066939A3
WO2004066939A3 PCT/US2004/002142 US2004002142W WO2004066939A3 WO 2004066939 A3 WO2004066939 A3 WO 2004066939A3 US 2004002142 W US2004002142 W US 2004002142W WO 2004066939 A3 WO2004066939 A3 WO 2004066939A3
Authority
WO
WIPO (PCT)
Prior art keywords
controlled
release
layers
drug
caps
Prior art date
Application number
PCT/US2004/002142
Other languages
French (fr)
Other versions
WO2004066939A2 (en
Inventor
Thomas Deveney
George Pawlo
David Friend
Kerrie Ziegler
Original Assignee
Sarnoff Corp
Thomas Deveney
George Pawlo
David Friend
Kerrie Ziegler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sarnoff Corp, Thomas Deveney, George Pawlo, David Friend, Kerrie Ziegler filed Critical Sarnoff Corp
Publication of WO2004066939A2 publication Critical patent/WO2004066939A2/en
Publication of WO2004066939A3 publication Critical patent/WO2004066939A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Abstract

A controlled-release drug delivery system (100) advantageously includes an open-ended, inflexible sleeve(102), at least two controlled-release layers (106) and two open-center caps (112). Each controlled-release layer (106) abuts a sealing surface (104) that is located within and near each end of the sleeve (102). The caps (112) seal each controlled-release layer (106) against the abutting sealing surface (104). One or more dose units of drug are disposed in a region that is formed between the controlled-release layers (114). The controlled-release layers dissolve, at a predetermined rate, by the action of body fluids that are in contact with those layers (106) through the center of the caps (112). Release of drug is delayed at least until the controlled-release layers (106) dissolve. The dose unit itself, which is advantageously a core, can be tailored to provide an extended period of drug release. One or more dose units that provide an immediate release component can also be disposed near each end of the sleeve (102).
PCT/US2004/002142 2003-01-27 2004-01-26 Controlled-release drug delivery system WO2004066939A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44285903P 2003-01-27 2003-01-27
US60/442,859 2003-01-27

Publications (2)

Publication Number Publication Date
WO2004066939A2 WO2004066939A2 (en) 2004-08-12
WO2004066939A3 true WO2004066939A3 (en) 2005-02-24

Family

ID=32825268

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/002142 WO2004066939A2 (en) 2003-01-27 2004-01-26 Controlled-release drug delivery system

Country Status (2)

Country Link
US (1) US20050019400A1 (en)
WO (1) WO2004066939A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2305634C (en) 1998-01-30 2006-01-03 Novo Nordisk A/S An injection syringe
TW453884B (en) 1999-09-16 2001-09-11 Novo Nordisk As Dose setting limiter
US6663602B2 (en) * 2000-06-16 2003-12-16 Novo Nordisk A/S Injection device
GB0304822D0 (en) 2003-03-03 2003-04-09 Dca Internat Ltd Improvements in and relating to a pen-type injector
US9205197B2 (en) 2003-03-03 2015-12-08 Sanofi-Aventis Deutschland Gmbh Drug delivery device dose setting mechanism
GB0308267D0 (en) * 2003-04-10 2003-05-14 Dca Design Int Ltd Improvements in and relating to a pen-type injector
ATE444090T1 (en) 2004-10-21 2009-10-15 Novo Nordisk As SELECTION MECHANISM FOR A ROTARY PIN
EP1855744A1 (en) * 2005-02-28 2007-11-21 Novo Nordisk A/S A dose setting mechanism for an injection device
EP1877121B1 (en) * 2005-04-24 2015-09-23 Novo Nordisk A/S Injection device
JP5183499B2 (en) 2006-03-10 2013-04-17 ノボ・ノルデイスク・エー／エス Injection device
JP5062768B2 (en) 2006-03-10 2012-10-31 ノボ・ノルデイスク・エー／エス INJECTION DEVICE AND METHOD FOR REPLACING CARTRIDGE OF THE DEVICE
DE602007004972D1 (en) 2006-05-16 2010-04-08 Novo Nordisk As GEARING MECHANISM FOR AN INJECTION DEVICE
AU2007253481B2 (en) 2006-05-18 2013-01-17 Novo Nordisk A/S An injection device with mode locking means
PL2109474T5 (en) 2007-02-05 2019-07-31 Novo Nordisk A/S Injection button
JP5230722B2 (en) * 2007-03-23 2013-07-10 ノボ・ノルデイスク・エー／エス Injection device with lock nut
EP2182917B1 (en) * 2007-07-06 2011-07-13 BASF Corporation A gastroretentive composition on the basis of a water-soluble reaction product from a vinyl group- containing precursor
EP2393513B1 (en) 2009-02-06 2016-10-19 The General Hospital Corporation Methods of treating vascular lesions
US9532952B2 (en) * 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
JP6069351B2 (en) 2011-12-29 2017-02-01 ノボ・ノルデイスク・エー／エス Torsion spring type automatic syringe with dial-up / dial-down administration mechanism
CN111050750A (en) 2017-08-24 2020-04-21 诺沃挪第克公司 GLP-1 compositions and uses thereof
EP4106727A1 (en) 2020-02-18 2022-12-28 Novo Nordisk A/S Pharmaceutical formulations

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898733A (en) * 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
US6340360B1 (en) * 1993-07-02 2002-01-22 Med Usa System for cell growth
US20020102307A1 (en) * 2000-04-26 2002-08-01 Hong Guo Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US102307A (en) * 1870-04-26 Improvement in wrenches

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898733A (en) * 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
US6340360B1 (en) * 1993-07-02 2002-01-22 Med Usa System for cell growth
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
US20020102307A1 (en) * 2000-04-26 2002-08-01 Hong Guo Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof

Also Published As

Publication number Publication date
US20050019400A1 (en) 2005-01-27
WO2004066939A2 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
WO2004066939A3 (en) Controlled-release drug delivery system
Rees et al. Guidelines for the management of the acute painful crisis in sickle cell disease
WO2007073702A3 (en) Multi-layered tablet with triple release combination
WO2006002275A3 (en) Catheters incorporating valves and permeable membranes
IL155347A0 (en) Devices, systems and methods of the containment and use of liquid solutions
WO2006068921A3 (en) Device for ophthalmic drug delivery
WO2006138658A3 (en) Permeant delivery system and methods for use thereof
AU2002361159A1 (en) Medicament dispenser with magneto-rheological fluid acuator
WO2002066002A3 (en) Pharmaceutical formulation
WO2007017725A3 (en) Container
WO2006116718A3 (en) Pharma-informatics system
WO2008011169A3 (en) Controlled release formulations and associated methods
WO2004021850A3 (en) Fluid delivery mechanism
WO2006073950A3 (en) Nanoparticles for protein drug delivery
WO2008062440A3 (en) Programmable buoyant delivery technology
WO2006022996A3 (en) Dosage form containing multiple drugs
WO2006023644A3 (en) Transdermal drug delivery device with translucent protective film
EA008159B8 (en) Hose end fitting
WO2009014916A3 (en) Drug eluting medical device and method
WO2006031284A3 (en) Covered stent with controlled therapeutic agent diffusion
WO2006007671A3 (en) Therapeutically combinations
WO2004028504A8 (en) Modified release dosage forms
AU2002345995A1 (en) Contrast delivery syringe with internal hydrophilic surface treatment for the prevention of bubble adhesion
WO2006124753A3 (en) Antipyretic agents against vr1-antagonist-induced increases in body temperature
WO2006021692A8 (en) Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004705298

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2004705298

Country of ref document: EP